Original language | English (US) |
---|---|
Article number | 5633 |
Pages (from-to) | 290 |
Number of pages | 1 |
Journal | Journal of Hepatology |
Volume | 63 |
Issue number | 1 |
DOIs |
|
State | Published - Jul 1 2015 |
ASJC Scopus subject areas
- Hepatology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of Hepatology, Vol. 63, No. 1, 5633, 01.07.2015, p. 290.
Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - Erratum
T2 - Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites (J Hepatol (2015) 62 (968-974) DOI: 10.1016/j.jhep.2014.12.029 PII: S0168827814009581)
AU - Angeli, Paolo
AU - Ginès, Pere
AU - Wong, Florence
AU - Bernardi, Mauro
AU - Boyer, Thomas D.
AU - Gerbes, Alexander
AU - Moreau, Richard
AU - Jalan, Rajiv
AU - Sarin, Shiv K.
AU - Piano, Salvatore
AU - Moore, Kevin
AU - Lee, Samuel S.
AU - Durand, Francois
AU - Salerno, Francesco
AU - Caraceni, Paolo
AU - Kim, W. Ray
AU - Arroyo, Vicente
AU - Garcia-Tsao, Guadalupe
N1 - Funding Information: PG: Research funding from Sequana Medical, Grifols SA; Consultancy Advisor to Ferring Pharmaceuticals; Competitive Public Grant Funding from: Fondos de Investigación Instituto de Salud CarlosIII ( FIS12/0330 ), Spain, Agència de Gestió d’Ajuts Universitaris i de Recerca (2014 SGR 708), Cataluña, Spain and research grant EC07/90077, integrated in the Plan Nacional I+D+I and co-funded by ISCIII-Subdirección General de Evaluación and European Regional Development Fund (ERDF). MB: Consultant to CSL Behring GmbH, Baxter Healthcare SA; speaker to Behring GmbH, Baxter Healthcare SA, PPTA Europe. AG: Consultant to CSL Behring. RJ: Consultant to Ocera Therapeutics Inc, Conatus Pharmaceuticals Inc; Research grant from: Grifols Inc, Gambro AB, Sequana Medical AG, Norgine BV, Ocera Therapeutics Inc (the latter five companies are all involved in research collaboration); Speaker to Grifols Inc; Norgine BV; Inventors of Ornithine Phenylacetate licensed by UCL to Ocera Therapeutics; UCL spinout Yaqrit which will in-licence five of the following inventions in which R Jalan is the main inventor: YAQ001 nanoporous carbons for prevention of gut bacterial translocation, UCL liver dialysis device, DASIMAR biomarker for liver failure, Neutrophil for test: biomarker for predicting infection in decompensated cirrhotic patients, Urinary toll-like receptor 4: for differential diagnosis of renal dysfunction of cirrhosis. SSL: Consultant to Ikaria and Grifols. PC: Lecturer to Baxter Healthcare SA, Kedrion, Grifols. VA: Received grant and research support from Grifols.
PY - 2015/7/1
Y1 - 2015/7/1
UR - http://www.scopus.com/inward/record.url?scp=84931571237&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84931571237&partnerID=8YFLogxK
U2 - 10.1016/j.jhep.2015.04.001
DO - 10.1016/j.jhep.2015.04.001
M3 - Comment/debate
AN - SCOPUS:84931571237
SN - 0168-8278
VL - 63
SP - 290
JO - Journal of Hepatology
JF - Journal of Hepatology
IS - 1
M1 - 5633
ER -